← Back to Search

Telehealth Support for Artificial Respiration (TEACH Trial)

N/A
Recruiting
Led By Colin Grissom, MD
Research Sponsored by Intermountain Health Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient age must be greater than or equal to 16 years and admitted to study hospital ICU
Patient must be intubated and mechanically ventilated
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

TEACH Trial Summary

This trial is testing if adding telehealth support to standard care improves patient outcomes for people on mechanical ventilation.

Who is the study for?
This trial is for patients aged 16 or older who are in the ICU and on artificial breathing support. It's not for those who passed away within a day of being put on a ventilator or were already brain dead when admitted for organ donation.Check my eligibility
What is being tested?
The study is testing if adding telehealth support to regular check-ups improves how well clinicians stick to protocols for waking up and breathing trials, which could lead to better outcomes for patients on ventilators.See study design
What are the potential side effects?
Since this trial involves procedural changes rather than medications, traditional side effects aren't expected. However, there may be risks associated with changing the usual care process.

TEACH Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 16 or older and currently in the ICU of the study hospital.
Select...
I am on a breathing machine.

TEACH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to C-SAT/SBT
Ventilator-free days to day 28
Secondary outcome measures
30-day Mortality
90-day Mortality
Hospital Length of Stay
+4 more

TEACH Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention - Telehealth- enabled support plus usual audit and feedback for SAT/SBT adherenceExperimental Treatment2 Interventions
Usual audit and feedback + telehealth-enabled support
Group II: Control - Usual audit/feedback for SAT/SBT adherence onlyActive Control1 Intervention
Usual audit and feedback

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,835 Previous Clinical Trials
47,297,270 Total Patients Enrolled
Intermountain Health Care, Inc.Lead Sponsor
137 Previous Clinical Trials
1,949,710 Total Patients Enrolled
University of UtahOTHER
1,099 Previous Clinical Trials
1,765,322 Total Patients Enrolled

Media Library

Telehealth-enabled support for SAT/SBT adherence Clinical Trial Eligibility Overview. Trial Name: NCT05141396 — N/A
Artificial Respiration Research Study Groups: Intervention - Telehealth- enabled support plus usual audit and feedback for SAT/SBT adherence, Control - Usual audit/feedback for SAT/SBT adherence only
Artificial Respiration Clinical Trial 2023: Telehealth-enabled support for SAT/SBT adherence Highlights & Side Effects. Trial Name: NCT05141396 — N/A
Telehealth-enabled support for SAT/SBT adherence 2023 Treatment Timeline for Medical Study. Trial Name: NCT05141396 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots remaining in this investigation?

"The details provided on clinicaltrials.gov reveal that this study, which was established in January 2024, is not presently enrolling patients. Fortunately for those seeking to participate in a trial of this type, there are 7 alternative investigations actively recruiting participants at the present time."

Answered by AI

How many health care facilities are participating in the research effort?

"Patients can seek out this medical trial at 11 sites, such as LDS Hospital in Salt Lake City, Cedar City Hospital in Cedar City and Intermountain Medical Center in Murray. Plus an additional 8 locations are available for enrollment."

Answered by AI
~7983 spots leftby Aug 2026